INTRODUCTION
The destruction of tumours by freezing is not new and much experimental work has been done using liquid nitrogen systems, on which current machines are based1-3.
However, there have been considerable recent advances in the equipment used for hepatic cryotherapy, the control offreezing by intra-operative ultrasound monitoring and advances in techniques for accurate probe placement 4,5. This procedure has largely been associated with little morbidity. The first large report of hepatic cryosurgery was in hepatocellular cancer6. There is now considerable evidence of reduction of serum CEA concentrations in patients with metastases from colorectal cancer v,8 after cryotherapy and there are encouraging survival results 9,10, with some patients in complete remission9. Hepatic cryotherapy has in our experience been a very safe procedure but we believe that this is at least partly due to the protocols of peri-operative care which have been formulated as result of our early experience and that of others1. We have used the L.C.S. System (Cryogenic Technology Ltd, Belper, UK) for all our cryotherapy work in Australia ( Figure 1 ). This is a large capacity system designed specifically for hepatic cryotherapy to deliver liquid nitrogen to the tip of a triple lumen probe applied to the lesion to be frozen. Large ice-balls form in the tissue surrounding the probe. The shaft ofthe probe is insulated, allowing precise destruction of deeply placed hepatic lesions without significant thermal damage to overlying liver tissue. We use three probes at present: 5mm and 9 mm insulated trocar probes and a flat plate probe ( Figure 2 ).
The current machine allows simultaneous use of two probes, although four-line machines are now available and would be an advantage for hepatic work and essential if prostatic cryotherapy is also to be done. A unique thaw system has been incorporated in the specially-engineered probe to allow quicker probe detachment after freezing. Heated nitrogen gas is used in the thawing process. Liquid nitrogen (30 liters) is stored in a double walled vacuum insulated storage vessel (Dewar) with the system. This is filled from a storage tank on site under pressure before the cryotherapy procedure. The Dewar pressure is maintained at 40 p.s.i, during cryotherapy but pressures up to 55 p.s.i, can be used. Lowering the pressure to a minimum of 25 p.s.i, is a method of preserving liquid nitrogen during a long freeze for a large lesion but we believe that flow rate is probably of importance in achieving ice balls ofadequate size for large livers. We use three types ofprobes ( Figure 2 ). The first flat probe can be applied to surface lesions, while the two long trocar-tipped probes are inserted into the centre of lesions. The larger probe (9 cm) results in faster freezing but clearly leaves a larger defect on extraction than the smaller probe (5 mm). We now very seldom use the flat plate probe because of the limited depth ofice ball that it achieves, although it can be suitable for ovarian tumour where relatively thin plaques of tumour can be seen or treating an inadequate margin ofliver resection. The freeze cycle should start at a Dewar pressure of40 p.s.i.. This pressure is maintained for at least five minutes before it can be reduced if a long freeze cycle is anticipated. Exhaust gas is vented through a tube from the proximal part ofthe probe. The exhaust gas can freeze objects in close proximity. Therefore the patient, skin, viscera and assistants should be protected form exhaust tubing. The inlet and exhaust tubes are supported by a hand-held gauze sling, to avoid contact with the patient. We now use a polystyrene insulated receptacle (beer cooler) attached to the exhaust tubing for exhaust gas, to avoid damaging theatre floors. The probes and exhaust tubing can be sterilized by autoclave, gas sterilisation or by immersion. Probes are sterilised by immersion for 10 minutes in gluteraldehyde solution. It is important that the immersion liquid is excluded from the insde of the probes and tubes by blanking off the tubes with stoppers and running gas through the system prior to using liquid nitrogen. Failure to do so will result in immediate blockage by frozen liquid on contact with gas.
The line assemblies are sterilised in a similar manner; the equipment is then rinsed with sterile water. Prior to the first freeze, we test run the probes in a container of saline to be sure that there is no leak of gas. A probe fracture could clearly expose the patient to the risk of gas embolism, although as soon as an ice ball is created, the path of least resistance will be out of the exhaust channel. We have not yet seen a probe failure in several thousand freeze/thaw cycles in our animal and clinical experience. .The joints in the system (probe/handle) should be tightened to prevent leakage of coolant. During freezing and thawing, the line assembly remains moderately pliable but the silicon exhaust tubing is rigid when frozen and is likely to fracture if moved. Two thermocouples are included in the L.C.S. 2000 but we also use a multi-channel computer-based recording system. These may be useful when monitoring the fringe of the iceball. However, we routinely rely on intra-operative ultrasound to monitor the size of the iceball (vide infra). After use, the equipment is cleaned with warm, soapy water and sterilizing solution, again ensuring that no liquid enters the apparatus.
The personnel required to operate the system safely include: the surgeon and assistant, scrub nurse, and one technician. The technician should be well trained in the operation ofthe L.C.S. 2000 system and be able to connect the various pipes during the procedure. Our technicians are also responsible for the intraoperative ultrasound machine and ultrasound dissagregator.
We have had no serious incidents or malfunction in over 90 procedures in patients. The commonest technical problem we have had is leakage ofliquid nitrogen between the line assembly and probe due to inadequate tightening prior to freezing and, occasionally, leaks at the joint between the L.C.S. 2000 machine and the line assembly due to inadequate fixation or, on one occasion, a cracked connector.
These include:-i) Hypothermia We Standard monitoring is applied to all patients. Other monitors are used to detect the possible intra-and postoperative sequelae ofhepatic cryotherapy (Table 3) . 
Application of CryoprobesAnd Cryotherapy
For small lesions on the surface ofthe liver, a trocar probe may be applied directly without penetration ofthe tumour.
For larger lesions at the surface, a trocar probe is inserted into the tumour under direct vision. For lesions deeply placed within the liver substance which cannot be easily palpated, a spinal needle is directed under ultrasound guidance into the centre of the tumour. The cryotherapy probe is inserted through the liver substance, using the spinal needle as a guide both for angle and depth and visualizing the process with the ultrasound. Multiple attempts at tumour access must be avoided with the relatively large cryoprobes. In addition, the track of the probe is chosen to avoid damage to major vessels and ducts. The inlet valve on the liquid nitrogen apparatus is opened to maximum and freezing commences. At this point, gauze swabs hold the inlet and outlet tubes away from the patient's body, protecting it from cold injury.
Cold gas from the exhaust should not come into contact with any object which may be damaged by cold. 
